News and Press Releases

Awen Oncology secures significant new funds to advance pioneering cancer therapeutics

23 April 2026 -- Anglesey, UK -- Awen Oncology, a pioneering Wales-based therapeutics company developing next-generation cancer treatments, has secured funds from a number of sources, worth seven figures, which...

Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: April 23, 2026

Symeres and Ambagon Therapeutics collaborate on molecular glue research in colorectal cancer

31 March 2026 -- Nijmegen, Netherlands -- Symeres, a leading CRDMO for drug discovery and development has partnered with Ambagon Therapeutics, a pre-clinical biotechnology company, to explore a new class...

Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: March 31, 2026

HeartBeat.bio and biotx.ai Sign License and Technology Access Agreement to Identify Novel Targets in Heart Failure

7 July 2025 -- Vienna, Austria and Berlin, Germany -- HeartBeat.bio AG and biotx.ai GmbH today announced a strategic partnership to identify and validate novel therapeutic targets in heart failure. The collaboration combines biotx.ai’s causal...

Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: July 7, 2025

Vienna Biocenter 6 Dr. Bohr-Gasse 7 A-1030 Vienna Austria

Upperton Continues Strategic Growth with the Appointment of Michael Mellor-Clark as Chief Commercial Officer.

9 April 2025 – Nottingham, UK – Upperton Pharma Solutions, a leading UK-based contract development and manufacturing organisation (CDMO), continues its growth following the build of a new sterile manufacturing...

Category:
Posted: April 9, 2025

Albert Einstein Centre, Nottingham Science Park, Nottingham, UK, NG7 2TN

ELRIG Announces Prof Rory Johnson and Dr Shalini Andersson as Keynote Speakers at Therapeutic Oligonucleotides 2025

Therapeutic Oligonucleotides 2025: Drugging the Undruggable takes place at AstraZeneca in Gothenburg, Sweden from 14–15 May 25 March 2025 -- Cambridge, UK -- ELRIG, a not-for-profit, volunteer-led organisation for the drug...

Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: March 25, 2025

ELRIG (UK) Ltd. Salisbury House, Station Road, Cambridge, CB1 2LA, UK

ELRIG Announces Drs Jue Wang and Robert Grundy as Keynote Speakers at Research & Innovation 2025

24 January 2025 -- Cambridge, UK -- The European Laboratory Research & Innovation Group (ELRIG), a not-for-profit, volunteer-led organisation for the drug discovery community, today announced the keynote speakers for Research...

Category: Drug Discovery, Other, Pharmaceutical
Posted: January 24, 2025

ELRIG (UK) Ltd. Salisbury House, Station Road, Cambridge, CB1 2LA, UK

Paris voted the ‘heart of pharma’ in Europe

Pharmapack Europe research reveals Île-de-France is the second-best location in Europe for ‘drug manufacturing’ and to ‘start a biotech’ Paris, France – The global drug delivery and packaging industry arrives...

Category:
Posted: January 13, 2025

Paris Expo, Porte de Versailles - Hall 7.2 | Paris, France

Dewpoint Therapeutics and Mitsubishi Tanabe Pharma Corporation Enter Research Collaboration to Advance Small Molecule Condensate Modulator for ALS

Both companies will collaborate to advance a small molecule condensate modulator targeting TDP-43, with the potential to address the underlying pathology of <97% of ALS patients Mitsubishi Tanabe Pharma Corporation...

Category: BioManufacturing, Drug Discovery
Posted: December 11, 2024

Dewpoint Therapeutics 451 D Street, Suite 104 Boston, MA 02210 USA

Relation announces two strategic collaborations with GSK to advance therapeutics for fibrotic diseases and osteoarthritis

Relation announces two strategic collaborations with GSK to advance therapeutics for fibrotic diseases and osteoarthritis 10 December 2024 -- London, UK -- Relation, an industry leader in deploying computation and...

Category: Drug Discovery, Other, Pharmaceutical
Posted: December 10, 2024

Regent’s Place 338 Euston Road London NW1 3BG

Seaport Therapeutics Names Lauren White as Chief Financial Officer

November 5, 2024 – Boston, MA, US – Seaport Therapeutics (“Seaport or the “Company”), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team,...

Category: Biotechnology
Posted: November 5, 2024

6 Tide Street, Suite 400, Seaport Boston, MA 02210

Hays appoints new Global Head of Life Sciences

18 October 2024 – London, UK – Hays, the global leader in workforce solutions and specialist recruitment, is pleased to announce the appointment of James Nyssen as Global Head of...

Category: Pharmaceutical
Posted: October 22, 2024

Hays plc 4th Floor 20 Triton Street Regent's Place London NW1 3BF

DRUG DISCOVERY 2024: CONNECTING MINDS, TRANSFORMING SCIENCE, EMPOWERING COMMUNITY

We are proud to be media partners of ELRIG's Drug Discovery 2024! Europe’s largest conference for the drug discovery community returns to London, with scientific tracks covering not only therapeutic...

Category: Drug Discovery
Posted: August 29, 2024

ELRIG (UK) Ltd. Salisbury House, Station Road, Cambridge, CB1 2LA, UK

Evotec and Pfizer collaborate to advance drug discovery in France

Multi-year collaboration will initially focus on early discovery research for metabolic and infectious diseases 11 July 2024, Hamburg, Germany – Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:...

Category: Drug Discovery
Posted: July 11, 2024

Just – Evotec Biologics, Inc. 401 Terry Avenue North Seattle, WA 98109, US

Enterprise Therapeutics publishes preclinical profile of ETD001, a novel inhaled ENaC blocker

Low doses of ETD001 demonstrate exceptionally long duration of action in sheep model of airway mucus clearance Report in Journal of Cystic Fibrosis discloses best-in-class profile of ETD001 ETD001 scheduled...

Category: Biotechnology, Clinical Trials, Drug Delivery, Drug Discovery, Pharmaceutical
Posted: June 12, 2024

Sussex Innovation Centre, University of Sussex, Science Park Square, Falmer, Brighton, BN1 9SB, UK

Oxford Drug Design and CRUK Scotland Institute awarded MRC grant funding to advance novel cancer therapeutics discovery

Collaboration to use genetically engineered mouse models to validate a new approach to cancer therapy 4 June 2024 - United Kingdom - The CRUK (Cancer Research UK) Scotland Institute and Oxford...

Category: Drug Discovery
Posted: June 10, 2024

Oxford Drug Design Lt,d Oxford Centre for Innovation, New Road, Oxford, OX1 1BY, UK